Rosen, top ranked global counsel, encourages marinus pharmaceuticals, inc. investors to secure counsel before important deadline in securities class action first filed by the firm – mrns

New york, june 24, 2024 (globe newswire) -- why: rosen law firm, a global investor rights law firm, reminds purchasers of the securities of marinus pharmaceuticals, inc. (nasdaq: mrns) between march 17, 2021 and may 7, 2024, both dates inclusive (the “class period”), of the important august 5, 2024 lead plaintiff deadline in the securities class action first filed by the firm.
TOP Ratings Summary
TOP Quant Ranking